Friday, February 12, 2021 9:33:54 AM
People think that companies just start up and fly off to dollar land.
The vast majority of companies don't make a profit till 5years+, some are longer. That doesn't mean they are crap it just means they are slow moving.
Also, testing in biopharma is like nuclear, littered with red tape and regulations so that is also slow moving.
That is why news about funding from NIH or FDA approval is such a huge thing in Biopharma because it tells investors "Our product works for the most part".
I am not worried about the toxicology study as I believe we already did one when we started testing in Bulgeria so it is a non-issue, more of a formality.
I have noticed these dips are almsot timed, very close to the middle and end of the month (around the 12~15th and the 27~30th almost like clock work and then boom, huge gains again.
Looks like another downer day
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM